📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: MyoKardia

1.1 - Company Overview

MyoKardia Logo

MyoKardia

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of targeted therapies for rare cardiovascular diseases, focusing on heritable cardiomyopathies and genetically driven forms of heart failure. The clinical-stage biopharmaceutical company discovers, develops, and commercializes targeted therapies.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to MyoKardia

Invatec Logo

Invatec

HQ: United States Website
  • Description: Provider of interventional coronary and peripheral products, focused on the development and commercialization of research-driven technologies. Headquartered in Europe, the company collaborates with physicians and centers of excellence to create products aimed at improving life expectancy.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Invatec company profile →
Angiodroid Logo

Angiodroid

HQ: Italy Website
  • Description: Provider of automatic carbon dioxide angiography solutions for hemodynamics, vascular surgery, and interventional radiology, including Angiodroid The CO2 Injector for peripheral diagnostic and interventional procedures, the Angiodroid Easy Kit disposable accessories, ANGIOPULSE counterpulsation weaning console, and the ACDA Academy offering training, articles, conferences, and live case streaming.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Angiodroid company profile →
Thoratec Logo

Thoratec

HQ: United States Website
  • Description: Provider of mechanical circulatory support medical devices for patients with advanced heart failure. A world leader with the broadest product portfolio, including HeartMate LVAS and Thoratec VAD, addressing the full range of clinical needs, with more than 20,000 devices implanted.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Thoratec company profile →
Semler Scientific Logo

Semler Scientific

HQ: United States Website
  • Description: Provider of medical risk-assessment solutions, including QuantaFlo software for non-invasive vascular disease risk assessment by evaluating extremity blood flow; SemlerShield for protection and security of medical data; SemlerVault for secure storage of sensitive medical information; SemlerAnalytics for insights and analytics on medical data; and SemlerSimulation, an online simulation-based training program for medical professionals.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Semler Scientific company profile →
BioCardia Logo

BioCardia

HQ: United States Website
  • Description: Provider of clinical-stage regenerative cardiology therapies and delivery systems, including CardiAMP autologous bone marrow cell therapy for heart failure, CardiALLO allogeneic mesenchymal stem cell therapy, the Helix system for minimally invasive biologic delivery to the heart, Morph DNA FDA-approved steerable introducer sheaths for cardiac/peripheral procedures, and the AVANCE bi-directional steerable introducer.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full BioCardia company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for MyoKardia

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to MyoKardia

2.2 - Growth funds investing in similar companies to MyoKardia

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for MyoKardia

4.2 - Public trading comparable groups for MyoKardia

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to MyoKardia

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About MyoKardia

What does MyoKardia do?

MyoKardia is a provider of targeted therapies for rare cardiovascular diseases, focusing on heritable cardiomyopathies and genetically driven forms of heart failure. The clinical-stage biopharmaceutical company discovers, develops, and commercializes targeted therapies.

Who are MyoKardia's competitors?

MyoKardia's competitors and similar companies include Invatec, Angiodroid, Thoratec, Semler Scientific, and BioCardia.

Where is MyoKardia headquartered?

MyoKardia is headquartered in United States.

How many employees does MyoKardia have?

MyoKardia has 1,000 employees 🔒.

When was MyoKardia founded?

MyoKardia was founded in 2010 🔒.

What sector and industry vertical is MyoKardia in?

MyoKardia is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for MyoKardia

Who are the top strategic acquirers in MyoKardia's sector and industry

Top strategic M&A buyers and acquirers in MyoKardia's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for MyoKardia?

Top strategic M&A buyers groups and sectors for MyoKardia include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in MyoKardia's sector and industry vertical

Which are the top PE firms investing in MyoKardia's sector and industry vertical?

Top PE firms investing in MyoKardia's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in MyoKardia's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in MyoKardia's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in MyoKardia's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to MyoKardia include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in MyoKardia's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for MyoKardia?

The key public trading comparables and valuation benchmarks for MyoKardia include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for MyoKardia for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for MyoKardia with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in MyoKardia's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for MyoKardia with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in MyoKardia's' sector and industry vertical?

Access recent funding rounds and capital raises in MyoKardia's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for MyoKardia